経済産業省

Newly Selected Startups Announced under the Public-Private Initiative for Supporting Startups Called the J-Startup Program

The Ministry of Economy, Trade and Industry (METI) hereby announces that it has newly selected 31 startups as J-Startup companies under the J-Startup program. These selected J-Startup companies are ...
BioWorld

Hebecell and Logomix establish partnership on gene-edited NK cells

Hebecell Corp. and Logomix Inc. have established a strategic partnership to research and develop gene-edited natural killer (NK) cells and discover genetic modifications that can create ...
Pharmaceutical Technology

HebeCell and Logomix partner to develop PSC-NK cells

Logomix will offer its genome-editing expertise to HebeCell to develop next-generation designer protoNK cells. Credit: Lightspring / Shutterstock.com. Biotechnology company HebeCell has entered a ...
Business Wire

HebeCell and Logomix Announce Collaboration for the Development of Next Gen Genomically Engineered PSC-NK Cells

BOSTON & TOKYO--(BUSINESS WIRE)--HebeCell Corp (HebeCell), a biotechnology company developing ProtoNK™ cell therapeutics based on its proprietary 3D PSC-NK manufacture platform, and Logomix Inc ...
BioSpace

HebeCell and Logomix Announce Collaboration for the Development of Next Gen Genomically Engineered PSC-NK Cells

HebeCell Corp (HebeCell) and Logomix Inc (Logomix) today announced a strategic partnership to research and develop gene-edited NK cells and discover genetic modifications that can create next ...
BioSpace

Logomix Inc. Raises $3.9M USD in Oversubscribed Seed Funding Round to Accelerate Its Platform and Portfolio Development.

Logomix, Inc., a Tokyo-based mammalian synthetic biology company developing artificial human cells for new therapeutics based on its pioneering Logomix, Inc., a Tokyo-based mammalian synthetic biology ...